Chlamydia Infections

02/01/2006 - "Treatment with an antibiotic effective against chlamydia infection was not associated with a statistically significant difference in preterm delivery. "
03/01/2005 - "Women receiving antibiotics effective against Chlamydia between randomization and follow-up or having symptomatic Chlamydia infection were excluded (26 women). "
12/01/2009 - "One biologically plausible explanation that requires further study is that fewer antibiotics are being prescribed that would inadvertently also treat chlamydia infection."
09/04/2021 - "Wild koalas with Chlamydia infections are admitted to wildlife hospitals and treated with antibiotics; however, up to 50% of koalas that present to wildlife hospitals do not survive. "
09/03/2021 - "The common treatment for chlamydia infections are antibiotics. "

09/01/1995 - "This study examined whether azithromycin is cost effective for treating cervical chlamydia infections. "
10/01/2014 - "We found that azithromycin was 96.1% (95% confidence interval, 91.1%-98.8%) effective in treating chlamydia infections, supporting its continued use. "
08/21/1993 - "Azithromycin is effective against Chlamydia trachomatis in vitro and as a single dose for the treatment of chlamydia infection of the genital tract. "
01/01/2016 - "This study describes the association between organism load and repeat rectal chlamydia infection, genovar distribution, and efficacy of azithromycin in asymptomatic MSM. "
12/24/2015 - "Recent studies have raised concern about the efficacy of azithromycin for the treatment of chlamydia infection. "

11/01/2019 - "These results provide valuable insight into the cellular mechanisms driving pathology in Chlamydia infection and contribute to the design and development of more effective vaccine strategies for protection against the deleterious sequelae of Chlamydia infection of the female reproductive tract."
10/01/2017 - "Determining the effector populations involved in humoral protection against genital chlamydia infection is crucial to development of an effective chlamydial vaccine. "
06/01/2009 - "Partially effective vaccines can still greatly reduce the incidence of chlamydia infection. "
06/01/2007 - "Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine."
01/01/2019 - "Mouse models are generally used for vaccine development, to study the immune response and histopathology associated with Chlamydia infection. "

05/01/2023 - "Doxycycline showed better results in NGU due to Chlamydia infection."
07/01/1997 - "In the PD model, clinically plausible changes in the probabilities of doxycycline cure, pelvic inflammatory disease, sequelae and chlamydia infection were found to alter the cost effectiveness outcome. "
12/24/2015 - "In the context of a closed population receiving directly observed treatment for urogenital chlamydia infection, the efficacy of azithromycin was 97%, and the efficacy of doxycycline was 100%. "
05/01/2015 - "The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis."
07/15/2014 - "We conducted a meta-analysis to compare the efficacy of 1 g azithromycin with 100 mg doxycycline twice daily (7 days) for the treatment of urogenital chlamydia infection. "

09/01/1991 - "Two antigen detection systems, Clearview Chlamydia (Unipath Ltd., Bedford, United Kingdom) and Chlamydiazyme (Abbott Laboratories, North Chicago, Ill.), were compared with culture for the diagnosis of chlamydia infection in women attending gynecological clinics. "
02/01/1991 - "We conclude that routine culture and EIA antigen tests detect only a minority of persistent chlamydia infections in this population, but subjective factors in the interpretation of DFA methods must be considered."
02/01/1991 - "Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology."
04/01/1984 - "T cell proliferative responses to Chlamydia trachomatis antigen in vitro in patients with a history of gynaecological chlamydia infection."
01/01/1983 - "In the years 1979-1981 a total of 775 individuals were subjected to medical and serological examinations for Chlamydia infection using the BIOVETA group antigen. "

08/06/2014 - "We also demonstrated that these four polymorphic membrane proteins (Pmps) individually conferred protection as measured by accelerated clearance of Chlamydia infection in the C57BL/6 murine genital tract model. "
05/01/2010 - "Therefore, in this study, we evaluated protection against Chlamydia infection in the genital tract in C57BL/6 mice immunized with Chlamydia-specific membrane proteins PmpG-1, PmpE/F-2, and major outer membrane protein (MOMP; as a reference) or a combination of them formulated with one of three adjuvants, CpG oligodeoxynucleotide (CpG-ODN), AbISCO-100 (AbISCO), or DDA/TDB (dimethyldioctadecylammonium bromide/D-(+)-trehalose 6,6'-dibehenate). "

01/01/2021 - "Studies have shown that interleukins is involved in the innate immune process after Chlamydia infection. "
01/01/2021 - "We summarized the role of interleukins in Chlamydia infection in order to provide reference for clinical treatment."
01/01/2021 - "[Interleukins in Chlamydia infection: An update]."
01/01/2013 - "Also among women with genital tract Chlamydia infection, peripheral CD3(+) CD4(+) and CD3(+) CD4(-) cells that proliferated in response to ex vivo stimulation with inactivated chlamydial antigen secreted significantly more interleukin (IL)-4 than tumor necrosis factor, interferon-γ, or IL-17; findings that repeated in T cells isolated from these same women 1 and 4 months after infection had been eradicated. "
01/01/2021 - "In the early stage of infection, Chlamydia, through receptor-mediated multiple signal transduction pathways, such as mitogen-activated protein kinase (MAPK), signal transducers and activators of transcription 3 (STAT3), myeloid differentiation factor 88 (MyD88) pathways, promotes the body to release a variety of pro-inflammatory interleukins, such as interleukin 1β (IL-1β), IL-6, IL-8 and IL-17, which inhibits Chlamydia replication and accelerates the clearance of Chlamydia. "

01/01/1989 - "Our patient presented with ascites secondary to Chlamydia infection and responded well to treatment with tetracycline. "
07/01/1989 - "The above findings might have implications for modifying the current Centers for Disease Control (CDC) recommendation to prescribe tetracycline for suspected Chlamydia infection among patients with gonorrhea."
08/01/1998 - "In the treatment of urogenital Chlamydia infections they are useful in the treatment of chronic infections after failure of previous macrolid and tetracycline therapy. "
01/01/1990 - "[The effect of tetracycline therapy on the laboratory indices of chlamydia infection in Reiter's disease (preliminary report)]."
01/01/1990 - "It has been established that tetracycline exerts an inhibitory effect on the chlamydia infection not in all the patients suffering from Reiter's disease despite sufficient concentration of the antibiotic in biological fluids (blood serum, synovial fluid). "

11/01/1986 - "Further study is needed to determine if an oral contraceptive increases the risk of Chlamydia infection in adolescents."
10/01/1986 - " Several studies show increased risk of endocervical chlamydia infection in users of oral contraceptives. "
07/01/2011 - "Parity, use of oral contraceptives, Chlamydia infection, and smoking as independent etiologic factors were not significantly associated with CIN relapse."
03/01/2008 - "Number of partners, oral contraceptive use and self-reported chlamydia infection increased the risk of having multiple HR HPV types (compared to having a single HR HPV type). "
01/01/2003 - "More positive cases of Chlamydia infection were found in oral contraceptive users (8.3%) than among non users (5.4%). "

04/01/2010 - "The studies have established that the combined use of ChlamiScan and ImmunoComb IgG in practical health care is most effective for the laboratory diagnosis of Chlamydia infection of the urogenital tract."
09/01/1995 - "However, for only half of Chlamydia IgG-positive patients could a Chlamydia infection be confirmed by urogenital swab culture. "
11/01/2020 - "Chlamydia status (positive/negative) was defined using chlamydia screening trial-nucleic acid amplification test results, chlamydia immunoglobulin G presence in serum, or self-reported chlamydia infections. "
01/01/2018 - "Seropositivity for HPV IgG was significantly associated with age at marriage (P < 0.001), current Chlamydia infection (P < 0.011), and number of children (P < 0.025), while seropositivty for HPV IgG and Chlamydia trahomatis IgM was significantly associated with age at coitarche (P < 0.028), number of life sex partners (P < 0.033), and history of multiple sexual partners (P < 0.002)."
09/08/2007 - "Following a chlamydia infection of the upper genital tract anti-chlamydia IgG antibodies are formed that may persist for a long time in serum. "

01/01/2023 - "Aim: To to increase the efficacy of the treatment of women diagnosed with complicated urogenital chlamydia infection based on the study of the immune status, clinical and pathogenetic features of the course, development and implementation of pathogenetically substantiated therapy methods. "
11/01/1985 - "Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn."
01/01/2022 - "Patient delivered partner therapy for chlamydia infection is used by some general practitioners, but more support is needed to increase uptake: findings from a mixed-methods study."
01/01/2022 - "Patient-delivered partner therapy: One option for management of sexual partner(s) of a patient diagnosed with a chlamydia infection."
01/01/2021 - "In the year following the implementation of the expedited partner therapy, compared with 419 women (mean±standard deviation, 23.4±5.5 years) who were diagnosed with chlamydia infection in the previous year, 471 women (mean±standard deviation age, 23.8±5.3 years) who delivered at our institution were diagnosed with chlamydia infection. "

08/13/2010 - "However, practicing regular condom use showed significant protection against chlamydia infection, not self confidence in condom negotiation. "
08/01/2011 - "Sexually active inconsistent condom users comprised 62% of the study population and contributed to 81% of the chlamydia infections. "
08/23/2007 - "This study showed a low prevalence of chlamydia infection among high school pupils, but much sexual activity and limited use of condom. "
08/10/2022 - "Reducing New Chlamydia Infection Among Young Men by Promoting Correct and Consistent Condom Use: Protocol for a Randomized Controlled Trial."
02/29/2016 - "Inconsistent condom use (odds ratio, OR = 5.5) and having had more than one sexual partner during the previous 6 months (OR = 6.8) were associated with an increased risk of Chlamydia infection at multivariate analysis. "

03/09/2002 - "From our experience with the STD, anonymous and free screening and the inter-disciplinary health education centres, we recommend the following: improved screening for HIV and other STD: concomitantly whenever possible, less invasive, free or reimbursed STD sampling, reliable and standardized techniques (polymerisation chain reaction or PCR and derivatives), itinerant screening for STD for persons who do not consult; ensured early, medical, social and psychological care of HIV and STD, emphasising the importance of compliance to treatment and prevention; ensured easy access and low cost of the male and female condoms; renewal and diversification of health relays, particularly in the private sector; staff training on STD and their epidemiological novelty; insisting on a transversal (HIV-other STD, curative-preventive, among others) and pragmatic approach (intervention studies resulting in local action); renewal of the information and advice for the public: information on the relationship between HIV and other STD, on the frequent STD that are lesser known, such as condyloma and chlamydia infections, emphasis on compliance to prevention measures (abstinence or use of condoms) during at least three months after a risk of HIV/STD transmission or after an STD has been identified and treated. "

06/01/1997 - "The four areas to be reviewed are: prevalence of genital chlamydia infection in women attending UK general practice; evidence for routine screening of women attending general practice; evidence for selective screening of women attending general practice; evidence for screening women requesting termination of pregnancy (TOP) or intrauterine device (IUD) insertion. "
08/01/1998 - "The most important complication attributed to the use of intrauterine device (IUD) is pelvic inflammatory disease (PID), often associated with Neisseria or Chlamydia infection. "
04/01/2015 - "There are many strongly documented causes of tubal infertility: infections (Chlamydia Trachomatis, Gonorrhea, and genital tuberculosis), intrauterine contraceptive devices, endometriosis, and complications after abdominal surgery, etc. Although there are still many controversies about the etiology of tubal sterility with the advent of molecular diagnosis of infections there has been cleared the pathway of infection through endometriosis or through ciliary immobility towards the tubal obstruction."
01/01/2021 - "Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place."
05/08/1985 - "Contraceptive use was similar except that intrauterine devices were used less frequently by patients with chlamydia infection. "

09/01/2020 - "[Evaluation of the influence of systemic enzyme therapy on immune reactions in genitourinary chlamydia infection]."
01/01/2012 - "The use of systemic enzyme therapy in combination with antibiotics in the treatment of urogenital chlamydia infection in patients of both sexes proved to improve the therapeutic efficacy and to reduce the risk of the side effects."